FLAIR: Switch to Long-Acting CAB + RPV Following Oral Induction in ART-Naive Patients Noninferior to Continued DTG/ABC/3TC at Week 48

Vlog from Clinical Care Options (CCO) and Dr. Jehan Budak demonstrating HIV-ASSIST to guide ART selection in a HTE patient with HIV. Review of NRTI, NNRTI, PI, INSTI mutations, and more.

Jehan Budak, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Physician Assistants: maximum of 0.25 hour of AAPA Category ICME credit ABIM MOC: maximum of 0.25 Medical Knowledge MOC point(s) Released: July 27, 2021 Expired: July 26, 2022

Interim results from the Phase II CALIBRATE study of lenacapavir in treatment-naive PLWH, reported by Clinical Care Options (CCO) from IAS 2021

Large, retrospective analysis supports the effectiveness and safety of dolutegravir-based regimens among children and adolescents, reported by Clinical Care Options (CCO) from IAS 2021

IAS 2021 report from Clinical Care Options (CCO): CUSTOMIZE study shows that HCPs think monthly injectable CAB + RTV LA is feasible and acceptable despite COVID-19 disruptions